Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Successful execution of any initiative requires a thorough plan that accounts for both the “knowns” and “unknowns”. Wouldn’t it be great to be able to proactively account for the unknowns and plan accordingly? Evolving how Medical Affairs informs their Strategic Planning Process requires a transformation from the traditional and puts Medical Affairs in the driver’s seat with an on-demand navigation. By joining this webinar, you will gain background on best practices and real-world examples of how this type of a transformative approach provides cross functional value and global alignment.
Innovate the way in which you plan and make decisions by taking an evidence-based approach to strategic planning and the strategic planning process. By leveraging data, we can gain actionable insight that will drive strategy and propel Medical Affairs efforts across data generation, dissemination and stakeholder engagement throughout a products life cycle.
After participating in this Webinar, participants will be better able to:
• Understand how you can utilize an informed approach to decision making to drive the strategic planning process
• Gain insight into the value data can bring to Medical Affairs during strategic planning cycles throughout the year
• Obtain a working knowledge of how cross-functional teams within Medical Affairs can apply insights gleaned from data to enhance utilization and the impact of efforts
As HCP reliance upon digital and social channels as both a source of educational information and a central meeting place for peer-to-peer interaction continues to increase, it’s critical for Medical Affairs teams to monitor that activity, understand who the Digital Opinion Leaders (DOLs) are and engage them appropriately.
In this session we will provide perspectives on the evolving role of Digital Opinion Leaders in medical education and share approaches for identifying, monitoring and engaging them in a compliant manor with relevant examples.
This series will provide you with tools to critically process and analyze medical scientific literature. You will get a good understanding of basic statistical concepts and theory that enable you to explain, understand and interpret data. These Webinars are practical and based on published articles and the analysis of these. You will work with the theory in practice to increase your understanding of the strengths and weaknesses of the statistics in scientific literature.
Statistical analysis in clinical trials
– Null/alternative hypotheses
– Statistical assumptions (type I error, significance level, type II error, statistical power,)
– Hypothesis testing
– Statistical tests
Statistics used in RCTs
– Type of outcome measures (dichotomous, continuous, time-to-event)
– Statistics used for analysis of dichotomous data (relative risk, odds ratio, risk difference, NNT)
– Analysis of time-to-event variables (plotting and interpretation of Kaplan-Meier curves)
Early Access includes a variety of programs by which pharmaceutical companies make investigational therapies available to patients with life-threatening diseases. These patients have either exhausted available treatments or have no approved options. This presentation will review the processes and procedures to consider in the implementation of an Early Access Program and explore the opportunities and challenges posed therein.
At the end of this webinar the participant will be able to:
At the conclusion of this eCademy Webinar, participants will be better able to understand:
As healthcare continues to transform, we need to stay connected to our customers in many ways. From Upstream scientific exchange driving research, to clinical trial design establishing evidence, to co-creation workshops establishing value propositions, to education and post-release support to drive adoption, collaboration with customers across the solution lifecycle is key to providing the best solutions to our customers. MSLs are becoming more important and playing key roles across the lifecycle in partnership with many others who play important roles. We will describe the landscape, drivers, and opportunities for engaging with customers across the lifecycle and how we socialize learnings across the organization.
The Scientific Communication Platform (SCP) is the foundation of a strong medical communications strategy for a pharmaceutical product or device, and serves as an important tool to align communications and messaging across functional areas. Even minor discrepancies in cited data and/or the way that data are described can lead to confusion and weaken a product’s overall value proposition. The SCP is based on scientific evidence and requires an in-depth analysis and review of available and anticipated data, the disease and competitive landscape, stakeholder perceptions, and aspirations about the product profile. Since the final SCP output ensures accurate and consistent language and referencing through all communication activities, putting a plan in place to ensure successful cross-functional and regional implementation and utilization of this valuable resource is critical.
After completing this Webinar, participants will be better able to:
This series will provide you with tools to critically process and analyze medical scientific literature. You will get a good understanding of basic statistical concepts and theory that enable you to explain, understand and interpret data. These Webinars are practical and based on published articles and the analysis of these. You will work with the theory in practice to increase your understanding of the strengths and weaknesses of the statistics in scientific literature.
Health technology and value assessment can be conducted using a variety of methods. Dr. Malone will provide an overview of those methods and an introduction on how to interpret the results from cost-effectiveness studies. This webinar will also discuss issues with defining value for health technologies, especially pharmaceuticals.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.